1
TÍTULO: Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study
AUTORES: Castagna, A; Maggiolo, F; Penco, G; Wright, D; Mills, A; Grossberg, R; J.-M Molina; Chas, J; Durant, J; Moreno, S; Doroana, M; Ait-Khaled, M; Huang, J; Min, S; Song, I; Vavro, C; Nichols, G; Yeo, JM; Aberg, J; Akil, B; Arribas, JR; J.- G Baril; Blanco Arevalo, JL; Blanco Quintana, F; Blick, G; Boix Martinez, V; Bouchaud, O; Branco, T; Bredeek, UF; Castro Iglesias, M; Clumeck, N; Conway, B; DeJesus, E; J.- L Delassus; De Truchis, P; Di Perri, G; Di Pietro, M; Duggan, J; Duvivier, C; Elion, R; Eron, J; Fish, D; Gathe, J; Haubrich, R; Henderson, H; Hicks, C; Hocqueloux, L; Hodder, S; C.- B Hsiao; Katlama, C; Kozal, M; Kumar, P; Lalla-Reddy, S; Lazzarin, A; Leoncini, F; Llibre, JM; Mansinho, K; Morlat, P; Mounzer, K; Murphy, M; Newman, C; Nguyen, T; Nseir, B; Philibert, P; Pialoux, G; Poizot-Martin, I; Ramgopal, M; Richmond, G; Salmon Ceron, D; Sax, P; Scarsella, A; Sension, M; Shalit, P; Sighinolfi, L; Sloan, L; Small, C; Stein, D; Tashima, K; Tebas, P; Torti, C; Tribble, M; Troisvallets, D; Tsoukas, C; Viciana Fernandez, P; Ward, D; Wheeler, D; Wilkin, T; G.- P Yeni; Louise Martin-Carpenter, J; Uhlenbrauck, G; ...Mais
PUBLICAÇÃO: 2014, FONTE: JOURNAL OF INFECTIOUS DISEASES, VOLUME: 210, NÚMERO: 3
INDEXADO EM: Scopus WOS CrossRef